Literature DB >> 32049053

Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression.

Maria Fasolino1, Naomi Goldman1, Wenliang Wang1, Benjamin Cattau1, Yeqiao Zhou2, Jelena Petrovic2, Verena M Link3, Allison Cote4, Aditi Chandra1, Michael Silverman5, Eric F Joyce6, Shawn C Little7, Klaus H Kaestner8, Ali Naji9, Arjun Raj4, Jorge Henao-Mejia10, Robert B Faryabi2, Golnaz Vahedi11.   

Abstract

Genetics is a major determinant of susceptibility to autoimmune disorders. Here, we examined whether genome organization provides resilience or susceptibility to sequence variations, and how this would contribute to the molecular etiology of an autoimmune disease. We generated high-resolution maps of linear and 3D genome organization in thymocytes of NOD mice, a model of type 1 diabetes (T1D), and the diabetes-resistant C57BL/6 mice. Multi-enhancer interactions formed at genomic regions harboring genes with prominent roles in T cell development in both strains. However, diabetes risk-conferring loci coalesced enhancers and promoters in NOD, but not C57BL/6 thymocytes. 3D genome mapping of NODxC57BL/6 F1 thymocytes revealed that genomic misfolding in NOD mice is mediated in cis. Moreover, immune cells infiltrating the pancreas of humans with T1D exhibited increased expression of genes located on misfolded loci in mice. Thus, genetic variation leads to altered 3D chromatin architecture and associated changes in gene expression that may underlie autoimmune pathology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D genome organization; HiChIP; T cell development; chromatin; enhancers; epigenetics; genome folding; non-obese diabetes mouse; pancreas; type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32049053      PMCID: PMC7152927          DOI: 10.1016/j.immuni.2020.01.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  68 in total

1.  The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137.

Authors:  P A Lyons; W W Hancock; P Denny; C J Lord; N J Hill; N Armitage; T Siegmund; J A Todd; M S Phillips; J F Hess; S L Chen; P A Fischer; L B Peterson; L S Wicker
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

Review 2.  CTCF: master weaver of the genome.

Authors:  Jennifer E Phillips; Victor G Corces
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

Review 3.  Ly49 receptors: evolution, genetic diversity, and impact on immunity.

Authors:  Mir Munir A Rahim; Andrew P Makrigiannis
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

4.  Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development.

Authors:  Douglas H Phanstiel; Kevin Van Bortle; Damek Spacek; Gaelen T Hess; Muhammad Saad Shamim; Ido Machol; Michael I Love; Erez Lieberman Aiden; Michael C Bassik; Michael P Snyder
Journal:  Mol Cell       Date:  2017-09-07       Impact factor: 17.970

5.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

6.  Cohesin-based chromatin interactions enable regulated gene expression within preexisting architectural compartments.

Authors:  Vlad C Seitan; Andre J Faure; Ye Zhan; Rachel Patton McCord; Bryan R Lajoie; Elizabeth Ing-Simmons; Boris Lenhard; Luca Giorgetti; Edith Heard; Amanda G Fisher; Paul Flicek; Job Dekker; Matthias Merkenschlager
Journal:  Genome Res       Date:  2013-09-03       Impact factor: 9.043

7.  OligoMiner provides a rapid, flexible environment for the design of genome-scale oligonucleotide in situ hybridization probes.

Authors:  Brian J Beliveau; Jocelyn Y Kishi; Guy Nir; Hiroshi M Sasaki; Sinem K Saka; Son C Nguyen; Chao-Ting Wu; Peng Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

8.  Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.

Authors:  Jeffrey C Barrett; David G Clayton; Patrick Concannon; Beena Akolkar; Jason D Cooper; Henry A Erlich; Cécile Julier; Grant Morahan; Jørn Nerup; Concepcion Nierras; Vincent Plagnol; Flemming Pociot; Helen Schuilenburg; Deborah J Smyth; Helen Stevens; John A Todd; Neil M Walker; Stephen S Rich
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

9.  The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV.

Authors:  Rebecca S Treger; Scott D Pope; Yong Kong; Maria Tokuyama; Manabu Taura; Akiko Iwasaki
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

10.  The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes.

Authors:  Charles A Steward; Jose M Gonzalez; Steve Trevanion; Dan Sheppard; Giselle Kerry; James G R Gilbert; Linda S Wicker; Jane Rogers; Jennifer L Harrow
Journal:  Database (Oxford)       Date:  2013-05-31       Impact factor: 3.451

View more
  26 in total

1.  EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.

Authors:  Yeqiao Zhou; Jelena Petrovic; Jingru Zhao; Wu Zhang; Ashkan Bigdeli; Zhen Zhang; Shelley L Berger; Warren S Pear; Robert B Faryabi
Journal:  Mol Cell       Date:  2022-02-18       Impact factor: 17.970

Review 2.  Conservation and divergence in gene regulation between mouse and human immune cells deserves equal emphasis.

Authors:  Sarah E Gilbertson; Amy S Weinmann
Journal:  Trends Immunol       Date:  2021-11-02       Impact factor: 16.687

3.  Aire regulates chromatin looping by evicting CTCF from domain boundaries and favoring accumulation of cohesin on superenhancers.

Authors:  Kushagra Bansal; Daniel A Michelson; Ricardo N Ramirez; Aaron D Viny; Ross L Levine; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-21       Impact factor: 12.779

Review 4.  Three-dimensional genome organization in immune cell fate and function.

Authors:  Sergi Cuartero; Grégoire Stik; Ralph Stadhouders
Journal:  Nat Rev Immunol       Date:  2022-09-20       Impact factor: 108.555

5.  TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors.

Authors:  Wenliang Wang; Aditi Chandra; Naomi Goldman; Sora Yoon; Emily K Ferrari; Son C Nguyen; Eric F Joyce; Golnaz Vahedi
Journal:  Nat Immunol       Date:  2022-06-20       Impact factor: 31.250

6.  Multiscale 3D genome organization underlies ILC2 ontogenesis and allergic airway inflammation.

Authors:  Michaël F Michieletto; John J Tello-Cajiao; Walter K Mowel; Aditi Chandra; Sora Yoon; Leonel Joannas; Megan L Clark; Monica T Jimenez; Jasmine M Wright; Patrick Lundgren; Adam Williams; Christoph A Thaiss; Golnaz Vahedi; Jorge Henao-Mejia
Journal:  Nat Immunol       Date:  2022-09-01       Impact factor: 31.250

Review 7.  3D Genome Organization as an Epigenetic Determinant of Transcription Regulation in T Cells.

Authors:  George Papadogkonas; Dionysios-Alexandros Papamatheakis; Charalampos Spilianakis
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

Review 8.  Remodeling the chromatin landscape in T lymphocytes by a division of labor among transcription factors.

Authors:  Golnaz Vahedi
Journal:  Immunol Rev       Date:  2021-01-15       Impact factor: 12.988

Review 9.  Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.

Authors:  Patricia Solé; Pere Santamaria
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

10.  Chromatin Looping Links Target Genes with Genetic Risk Loci for Dermatological Traits.

Authors:  Chenfu Shi; Helen Ray-Jones; James Ding; Kate Duffus; Yao Fu; Vasanthi Priyadarshini Gaddi; Oliver Gough; Jenny Hankinson; Paul Martin; Amanda McGovern; Annie Yarwood; Patrick Gaffney; Steve Eyre; Magnus Rattray; Richard B Warren; Gisela Orozco
Journal:  J Invest Dermatol       Date:  2021-02-17       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.